Position in BLLN
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$4,065,488
New position
Shares Held
51,501
first reported quarter
Ownership
0.112%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Ensign Peak Advisors, Inc holds $595,311,140 across 25 Diagnostics & Research names. BLLN ranks #11 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
516,570 | $253,909,652 | |
| 2 | DHR |
Danaher Corp /De/
|
677,010 | $128,361,096 | |
| 3 | MTD |
Mettler Toledo International Inc/
|
45,682 | $57,614,138 | |
| 4 | NTRA |
Natera, Inc.
|
180,362 | $36,070,596 | |
| 5 | IDXX |
Idexx Laboratories Inc /De
|
41,370 | $23,245,389 | |
| 6 | IQV |
Iqvia Holdings Inc.
|
134,401 | $22,920,746 | |
| 7 | WAT |
Waters Corp /De/
|
59,950 | $17,853,110 | |
| 8 | A |
Agilent Technologies, Inc.
|
123,673 | $14,096,248 |
All Filings in BLLN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,065,488 | 51,501 | Shares | Sole | 2026-05-13 | |
| No filing history on record for this holder in this stock. | ||||||